Skip to main content
. Author manuscript; available in PMC: 2021 Mar 26.
Published in final edited form as: Laryngoscope. 2019 Oct 11;130(7):1828–1835. doi: 10.1002/lary.28325

TABLE IV.

Polysomnographic Parameters at Baseline and After Treatment for Children with Down Syndrome and Mild Obstructive Sleep Apnea by Treatment Group.

Characteristic Observation (n = 13) Oxygen (n = 1) Medication (n = 10) P
Baseline parameters
 oAHI, events/hour (95% CI) 2.9 (1.1–4.9) 3.3 (–) 3.5 (1.3–4.7) .96
 AHI, events/hour (95% CI) 3.3 (1.8–7.2) 8.2 (–) 3.5 (1.7–4.7) .24
 CAI, events/hour (95% CI) 0.5 (0–2.3) 4.9 (–) 0.25 (0–2) .20
 Oxyhemoglobin nadir, % (95% CI) 90 (82–96) 73 (–) 89 (80–94) .22
 Sleep efficiency, % total sleep time (95% CI) 83 (62–91) 87 87 (68–95) .67
 Arousal Index, event/hour (95% CI) 14.2 (9.1–32.7) 19.6 10.4 (6.2–18.5) .18
 End-tidal CO2 > 50 mmHg, min (95% CI) 0.1 (0–62) 0 (–) 0.1 (0–69) .63
 Percentage of REM sleep, % (95% CI) 22 (10–40) 28 (–) 22 (16–28) .55
Posttreatment polysomnogram parameters
 Posttreatment oAHI, events/hour, (95% CI) 3.6 (0.7–6.8) 1.1 (–) 3.6 (1.5–13.8) .45
 Posttreatment AHI, events/hour (95% CI) 4.1 (0.7–7.8) 4.7 (–) 3.7 (0.8–13.8) .82
 Posttreatment CAI, events/hour (95% CI) 0.4 (0–3.9) 3.6 (–) 0.25 (0–0.6) .18
 Posttreatment oxygen nadir, % (95% CI) 91 (73–95) 85 (–) 90 (73–92) .25
 Posttreatment sleep efficiency, % total sleep time (95% CI) 86 (71–96) 85 (–) 86 (77–98) .77
 Posttreatment Arousal Index, event/hour (95% CI) 12.3 (6.8–24.1) 12.1 (–) 13.3 (6.4–22.5) .97
 Posttreatment CO2 > 50 mmHg min (95% CI) 0 (0–79) 1.1 (–) 2.8 (0–79) .47
 Posttreatment percentage of REM sleep, % (95% CI) 24 (13–37) 25 (–) 24 (3–38) .69
 Posttreatment OSA severity (n, %) .82
  None 1 (7.7) 0 (0) 1 (10.0)
  Mild 10 (76.9) 1 (100.0) 6 (60.0)
  Moderate/severe 2 (15.4) 0 (0) 3 (30.0)

AHI = apnea-hypopnea index; CAI = central apnea index; CO2 = carbon dioxide; REM = rapid eye movement; oAHI = obstructive apnea-hypopnea index; OSA = obstructive sleep apnea.